Health care companies in the United States by P/B ratio
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
MiniMed Group has the lowest figure of the 128 health care companies in the United States ranked by P/B ratio, at 1.2, followed by Bio-Rad Laboratories (1.3) and CVS Health (1.3). Figures as of 21 Nov 2026, 07:07 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 128
- Lowest
- MiniMed Group1.2
- Median
- 5.3
- Combined market value
- NOK 71.18T
- Countries
- 1
- Not ranked
- 12no P/B ratio on file
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | P/B ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | MiniMed GroupMMED · Health Care | 1.2 | NOK 43.9B | NOK 156.09 | 1.54% down | 12% down | ||
| 2 | Bio-Rad LaboratoriesBIO · Health Care | 1.3 | NOK 94.1B | NOK 3,499.06 | 2.34% down | 16% up | ||
| 3 | CVS HealthCVS · Health Care | 1.3 | NOK 1.01T | NOK 788.14 | 1.00% up | 3% up | ||
| 4 | Cooper CompaniesCOO · Health Care | 1.3 | NOK 109.2B | NOK 574.04 | 2.40% down | 20% down | ||
| 5 | Universal Health ServicesUHS · Health Care | 1.4 | NOK 100.9B | NOK 1,749.33 | 2.54% up | 25% down | ||
| 6 | CenteneCNC · Health Care | 1.4 | NOK 307.8B | NOK 621.82 | 2.74% down | 80% up | ||
| 7 | Zimmer Biomet HoldingsZBH · Health Care | 1.5 | NOK 186.5B | NOK 985.66 | 0.36% down | 10% up | ||
| 8 | ViatrisVTRS · Health Care | 1.6 | NOK 219.4B | NOK 191.38 | 1.26% down | 90% up | ||
| 9 | Cigna GroupCI · Health Care | 1.6 | NOK 695.9B | NOK 2,641.11 | 0.78% down | 2% down | ||
| 10 | AvantorAVTR · Health Care | 1.7 | NOK 98B | NOK 144.68 | 1.85% down | 31% up | ||
| 11 | PfizerPFE · Health Care | 1.8 | NOK 1.52T | NOK 267.13 | 0.51% down | 10% up | ||
| 12 | GRAILGRAL · Health Care | 1.8 | NOK 43.5B | NOK 967.63 | 5.33% down | 12% up | ||
| 13 | Globus MedicalGMED · Health Care | 1.9 | NOK 86.4B | NOK 652.14 | 2.49% down | 20% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | 1.9 | NOK 114.1B | NOK 588.96 | 1.64% down | 12% up | ||
| 15 | TeleflexTFX · Health Care | 1.9 | NOK 62.5B | NOK 1,575.31 | 1.11% down | 48% up | ||
| 16 | Elevance HealthELV · Health Care | 1.9 | NOK 830.9B | NOK 3,845.94 | 1.11% up | 21% up | ||
| 17 | Elanco Animal HealthELAN · Health Care | 1.9 | NOK 125.4B | NOK 250.95 | 2.09% down | 18% up | ||
| 18 | BiogenBIIB · Health Care | 1.9 | NOK 359.7B | NOK 2,433.35 | 1.00% up | 41% up | ||
| 19 | Baxter InternationalBAX · Health Care | 2.0 | NOK 128.1B | NOK 247.54 | 0.00% | 39% up | ||
| 20 | RevvityRVTY · Health Care | 2.2 | NOK 158.1B | NOK 1,415.81 | 4.20% down | 54% up | ||
| 21 | Legend BiotechLEGN · Health Care | 2.3 | NOK 28.8B | NOK 148.68 | 5.28% down | 43% down | ||
| 22 | Becton, DickinsonBDX · Health Care | 2.4 | NOK 565.1B | NOK 2,074.48 | 0.05% up | 40% up | ||
| 23 | Boston ScientificBSX · Health Care | 2.4 | NOK 593.2B | NOK 409.28 | 2.35% down | 56% down | ||
| 24 | Molina HealthcareMOH · Health Care | 2.5 | NOK 101B | NOK 1,934.18 | 2.43% down | 44% up | ||
| 25 | HumanaHUM · Health Care | 2.5 | NOK 456.7B | NOK 3,802.27 | 2.63% up | 67% up | ||
| 26 | Align TechnologyALGN · Health Care | 2.5 | NOK 106.6B | NOK 1,512.81 | 2.82% down | 12% up | ||
| 27 | Edgewise TherapeuticsEWTX · Health Care | 2.7 | NOK 42.6B | NOK 389.05 | 3.07% down | 82% up | ||
| 28 | Regeneron PharmaceuticalsREGN · Health Care | 2.8 | NOK 928.6B | NOK 8,976.18 | 0.19% down | 22% up | ||
| 29 | MedlineMDLN · Health Care | 2.8 | NOK 475.2B | NOK 361.12 | 2.11% down | 8% down | ||
| 30 | WatersWAT · Health Care | 2.8 | NOK 843.9B | NOK 4,294.12 | 3.51% down | 16% up | ||
| 31 | DanaherDHR · Health Care | 2.9 | NOK 1.51T | NOK 2,148.38 | 3.16% down | 0% up | ||
| 32 | Merit Medical SystemsMMSI · Health Care | 2.9 | NOK 49.3B | NOK 822.26 | 0.08% down | 3% down | ||
| 33 | Henry ScheinHSIC · Health Care | 2.9 | NOK 90B | NOK 814.27 | 1.51% down | 16% up | ||
| 34 | SolventumSOLV · Health Care | 3.0 | NOK 140B | NOK 823.82 | 1.52% down | 3% up | ||
| 35 | UnitedHealth GroupUNH · Health Care | 3.1 | NOK 2.97T | NOK 3,313.33 | 2.84% up | 3% up | ||
| 36 | GE HealthCare TechnologiesGEHC · Health Care | 3.1 | NOK 355.5B | NOK 786.19 | 1.53% down | 7% up | ||
| 37 | VaxcytePCVX · Health Care | 3.3 | NOK 85.5B | NOK 540.02 | 5.09% down | 22% up | ||
| 38 | Labcorp HoldingsLH · Health Care | 3.4 | NOK 290.6B | NOK 3,579.30 | 0.47% down | 39% up | ||
| 39 | Oscar HealthOSCR · Health Care | 3.5 | NOK 74.9B | NOK 241.10 | 5.50% down | 94% up | ||
| 40 | Abbott LaboratoriesABT · Health Care | 3.5 | NOK 1.74T | NOK 1,004.19 | 0.84% down | 19% down | ||
| 41 | LifeStance Health GroupLFST · Health Care | 3.5 | NOK 51.2B | NOK 134.74 | 3.60% up | 107% up | ||
| 42 | Option Care HealthOPCH · Health Care | 3.6 | NOK 46.1B | NOK 307.98 | 0.06% down | 7% up | ||
| 43 | Quest DiagnosticsDGX · Health Care | 3.7 | NOK 277B | NOK 2,518.08 | 0.31% down | 35% up | ||
| 44 | United TherapeuticsUTHR · Health Care | 3.7 | NOK 230.3B | NOK 5,408.28 | 0.78% down | 18% up | ||
| 45 | BrukerBRKR · Health Care | 3.8 | NOK 84.1B | NOK 550.45 | 9.08% down | 31% up | ||
| 46 | Dianthus TherapeuticsDNTH · Health Care | 3.8 | NOK 46.4B | NOK 824.31 | 0.33% down | 105% up | ||
| 47 | Tenet HealthcareTHC · Health Care | 3.8 | NOK 204.2B | NOK 2,565.94 | 0.15% down | 37% up | ||
| 48 | Neurocrine BiosciencesNBIX · Health Care | 3.9 | NOK 148.6B | NOK 1,467.97 | 3.84% down | 10% up | ||
| 49 | HealthEquityHQY · Health Care | 3.9 | NOK 76.4B | NOK 923.76 | 2.70% down | 4% down | ||
| 50 | Ensign GroupENSG · Health Care | 4.0 | NOK 100.3B | NOK 1,719.01 | 0.15% down | 5% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | 4.0 | NOK 37.8B | NOK 276.30 | 3.87% down | 176% up | ||
| 52 | IncyteINCY · Health Care | 4.1 | NOK 227.8B | NOK 1,117.52 | 1.07% down | 14% up | ||
| 53 | RepligenRGEN · Health Care | 4.4 | NOK 102.1B | NOK 1,597.05 | 3.81% down | 5% up | ||
| 54 | Royalty PharmaRPRX · Health Care | 4.5 | NOK 383.7B | NOK 667.35 | 1.08% up | 74% up | ||
| 55 | Thermo Fisher ScientificTMO · Health Care | 4.5 | NOK 2.42T | NOK 6,527.61 | 2.79% down | 17% up | ||
| 56 | MSA SafetyMSA · Health Care | 4.6 | NOK 63.9B | NOK 1,657.69 | 3.52% down | 13% up | ||
| 57 | Charles River Laboratories InternationalCRL · Health Care | 4.7 | NOK 146.8B | NOK 3,064.43 | 4.15% down | 96% up | ||
| 58 | RadNetRDNT · Health Care | 4.9 | NOK 53.5B | NOK 679.63 | 0.29% up | 16% down | ||
| 59 | Encompass HealthEHC · Health Care | 4.9 | NOK 127.9B | NOK 1,303.01 | 1.04% up | 16% up | ||
| 60 | Lantheus HoldingsLNTH · Health Care | 4.9 | NOK 65.1B | NOK 995.41 | 0.00% | 83% up | ||
| 61 | StrykerSYK · Health Care | 5.0 | NOK 1.15T | NOK 3,022.31 | 0.98% down | 15% down | ||
| 62 | Bristol-Myers SquibbBMY · Health Care | 5.1 | NOK 1.17T | NOK 573.26 | 0.79% up | 26% up | ||
| 63 | ErascaERAS · Health Care | 5.2 | NOK 46.6B | NOK 132.69 | 4.29% down | 387% up | ||
| 64 | Bio-TechneTECH · Health Care | 5.3 | NOK 111.3B | NOK 708.49 | 0.04% down | 18% up | ||
| 65 | Alnylam PharmaceuticalsALNY · Health Care | 5.3 | NOK 187.8B | NOK 1,402.16 | 2.71% down | 66% down | ||
| 66 | Oruka TherapeuticsORKA · Health Care | 5.4 | NOK 63.4B | NOK 934.09 | 1.80% down | 233% up | ||
| 67 | Edwards LifesciencesEW · Health Care | 5.4 | NOK 571B | NOK 992.98 | 1.95% down | 22% up | ||
| 68 | ResMedRMD · Health Care | 5.6 | NOK 323.1B | NOK 2,297.25 | 0.53% down | 6% down | ||
| 69 | PACS GroupPACS · Health Care | 5.7 | NOK 67.6B | NOK 425.76 | 1.49% up | 56% up | ||
| 70 | InsuletPODD · Health Care | 5.9 | NOK 90.1B | NOK 1,298.33 | 2.96% down | 59% down | ||
| 71 | Ligand PharmaceuticalsLGND · Health Care | 6.0 | NOK 55.9B | NOK 2,796.62 | 0.03% down | 44% up | ||
| 72 | BrightSpring Health ServicesBTSG · Health Care | 6.0 | NOK 122B | NOK 613.14 | 1.77% down | 85% up | ||
| 73 | IQVIA HoldingsIQV · Health Care | 6.1 | NOK 395B | NOK 2,396.60 | 1.89% down | 11% up | ||
| 74 | HaemoneticsHAE · Health Care | 6.1 | NOK 53.3B | NOK 1,171.49 | 0.17% down | 53% up | ||
| 75 | Kymera TherapeuticsKYMR · Health Care | 6.1 | NOK 96B | NOK 1,124.20 | 3.42% down | 81% up | ||
| 76 | Vertex PharmaceuticalsVRTX · Health Care | 6.2 | NOK 1.27T | NOK 5,021.14 | 1.08% down | 22% up | ||
| 77 | VeradermicsMANE · Health Care | 6.3 | NOK 49.2B | NOK 1,165.25 | 3.92% down | 230% up | ||
| 78 | Krystal BiotechKRYS · Health Care | 6.4 | NOK 89.2B | NOK 3,011.49 | 2.19% down | 49% up | ||
| 79 | Agilent TechnologiesA · Health Care | 6.5 | NOK 468.4B | NOK 1,661.10 | 2.83% down | 16% up | ||
| 80 | Praxis Precision MedicinesPRAX · Health Care | 6.7 | NOK 81.9B | NOK 2,929.01 | 3.37% down | 83% up | ||
| 81 | Belite BioBLTE · Health Care | 6.7 | NOK 50.4B | NOK 1,241.88 | 15.65% down | 25% up | ||
| 82 | CG OncologyCGON · Health Care | 7.2 | NOK 69.2B | NOK 774.78 | 2.97% down | 93% up | ||
| 83 | Protagonist TherapeuticsPTGX · Health Care | 7.3 | NOK 77.3B | NOK 1,183.58 | 2.11% down | 45% up | ||
| 84 | Merck & CoMRK · Health Care | 7.3 | NOK 3.21T | NOK 1,303.69 | 0.69% up | 36% up | ||
| 85 | BillionToOneBLLN · Health Care | 7.6 | NOK 41.9B | NOK 876.67 | 0.31% down | 18% down | ||
| 86 | Caris Life SciencesCAI · Health Care | 7.9 | NOK 49.2B | NOK 171.39 | 5.18% down | 23% down | ||
| 87 | Twist BioscienceTWST · Health Care | 7.9 | NOK 68.7B | NOK 1,007.31 | 7.44% down | 291% up | ||
| 88 | PenumbraPEN · Health Care | 7.9 | NOK 122.6B | NOK 3,111.23 | 0.28% down | 11% up | ||
| 89 | Johnson & JohnsonJNJ · Health Care | 8.0 | NOK 6.35T | NOK 2,636.92 | 1.25% up | 31% up | ||
| 90 | 10x GenomicsTXG · Health Care | 8.1 | NOK 66.4B | NOK 505.02 | 9.72% down | 213% up | ||
| 91 | ChemedCHE · Health Care | 8.3 | NOK 69.3B | NOK 5,348.42 | 0.50% down | 25% up | ||
| 92 | Corcept TherapeuticsCORT · Health Care | 8.3 | NOK 67.9B | NOK 620.26 | 2.09% down | 16% down | ||
| 93 | ExelixisEXEL · Health Care | 8.6 | NOK 153.8B | NOK 630.10 | 1.82% down | 55% up | ||
| 94 | Intuitive SurgicalISRG · Health Care | 8.7 | NOK 1.35T | NOK 3,890.50 | 2.01% down | 27% down | ||
| 95 | West Pharmaceutical ServicesWST · Health Care | 9.2 | NOK 265.1B | NOK 3,805.19 | 1.61% down | 46% up | ||
| 96 | Spyre TherapeuticsSYRE · Health Care | 9.3 | NOK 86.5B | NOK 911.28 | 4.26% down | 302% up | ||
| 97 | IlluminaILMN · Health Care | 9.3 | NOK 284.2B | NOK 1,879.88 | 3.90% down | 62% up | ||
| 98 | Hims & Hers HealthHIMS · Health Care | 9.6 | NOK 33.4B | NOK 142.34 | 8.86% down | 54% down | ||
| 99 | ZoetisZTS · Health Care | 9.8 | NOK 313.4B | NOK 771.28 | 2.08% down | 34% down | ||
| 100 | ImmunovantIMVT · Health Care | 10.0 | NOK 64.1B | NOK 309.74 | 2.31% down | 44% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7494 NOK). 12 companies have no P/B ratio on file and are not ranked here.
Questions and answers
Which health care companies in the United States have the lowest P/B ratio?
MiniMed Group (1.2), Bio-Rad Laboratories (1.3) and CVS Health (1.3) have the lowest P/B ratio of the 128 health care companies in the United States ranked here as of 21 Nov 2026, 07:07 UTC.
How many health care companies in the United States are in this ranking?
128 are ranked by P/B ratio. 12 more have no P/B ratio on file and are left out rather than ranked at zero.
What are these health care companies in the United States worth together?
The 128 health care companies in the United States ranked by P/B ratio have a combined market value of NOK 71.18T as of 21 Nov 2026, 07:07 UTC.
What does ranking by P/B ratio measure?
Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Piotroski F-score: the nine tests and what they show
The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies in the United States by P/B ratio”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=pb-ratio
Underlying data: Yahoo Finance; SEC EDGAR.